Impact of Surgery on Quality of Life in Patients with Hepatocellular Carcinoma
详细信息 查看全文
- 作者：Yoshihiro Mise (1)
Shouichi Satou (1)
Takeaki Ishizawa (1)
Junichi Kaneko (1)
Taku Aoki (1)
Kiyoshi Hasegawa (1)
Yasuhiko Sugawara (1)
Masatoshi Makuuchi (2)
Norihiro Kokudo (1) - 刊名：World Journal of Surgery
- 出版年：2014
- 出版时间：April 2014
- 年：2014
- 卷：38
- 期：4
- 页码：958-967
- 全文大小：2,945 KB
- 参考文献：1. Hasegawa K, Kokudo N, Shiina S et al (2010) Surgery versus radiofrequency ablation for small hepatocellular carcinoma: start of a randomized controlled trial (SURF trial). Hepatol Res 40:851-52 CrossRef
2. Huang J, Yan L, Cheng Z et al (2010) A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 252:903-12 CrossRef
3. Zhou Y, Zhao Y, Li B et al (2010) Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol 10:78 CrossRef
4. Ganz PA, Moinpour CM, Cella DF et al (1992) Quality-of-life assessment in cancer clinical trials: a status report. J Natl Cancer Inst 84:994-95 CrossRef
5. Moinpour CM (1994) Measuring quality of life: an emerging science. Semin Oncol 21:48-0; discussion 60-3
6. Moinpour CM, Hayden KA, Thompson IM et al (1990) Quality of life assessment in Southwest Oncology Group trials. Oncology (Williston Park) 4(79-4):89; discussion 104
7. Nayfield SG, Ganz PA, Moinpour CM et al (1992) Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials. Qual Life Res 1:203-10 CrossRef
8. Wang YB, Chen MH, Yan K et al (2007) Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: comparison with transcatheter arterial chemoembolization alone. Qual Life Res 16:389-97 CrossRef
9. Steel J, Baum A, Carr B (2004) Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial infusion of cisplatin versus 90-yttrium microspheres (Therasphere). Psychooncology 13:73-9 CrossRef
10. Shun SC, Chiou JF, Lai YH et al (2008) Changes in quality of life and its related factors in liver cancer patients receiving stereotactic radiation therapy. Support Care Cancer 16:1059-065 CrossRef
11. Shun SC, Chen CH, Sheu JC et al (2012) Quality of life and its associated factors in patients with hepatocellular carcinoma receiving one course of transarterial chemoembolization treatment: a longitudinal study. Oncologist 17:732-39 CrossRef
12. Kondo Y, Yoshida H, Tateishi R et al (2007) Health-related quality of life of chronic liver disease patients with and without hepatocellular carcinoma. J Gastroenterol Hepatol 22:197-03 CrossRef
13. Hsu WC, Tsai AC, Chan SC et al (2012) Mini-nutritional assessment predicts functional status and quality of life of patients with hepatocellular carcinoma in Taiwan. Nutr Cancer 64:543-49 CrossRef
14. Gangeri L, Tamburini M, Borreani C et al (2002) Candidates for liver transplantation for cancer: physical, psychological, and social conditions. Transplantation 73:1627-635 CrossRef
15. Fan SY, Eiser C, Ho MC (2010) Health-related quality of life in patients with hepatocellular carcinoma: a systematic review. Clin Gastroenterol Hepatol 8(559-64):e1–e10
16. Ueno S, Tanabe G, Nuruki K et al (2002) Quality of life after hepatectomy in patients with hepatocellular carcinoma: implication of change in hepatic protein synthesis. Hepatogastroenterology 49:492-96
17. Tanabe G, Ueno S, Maemura M et al (2001) Favorable quality of life after repeat hepatic resection for recurrent hepatocellular carcinoma. Hepatogastroenterology 48:506-10
18. Lee LJ, Chen CH, Yao G et al (2007) Quality of life in patients with hepatocellular carcinoma received surgical resection. J Surg Oncol 95:34-9 CrossRef
19. Toro A, Pulvirenti E, Palermo F et al (2012) Health-related quality of life in patients with hepatocellular carcinoma after hepatic resection, transcatheter arterial chemoembolization, radiofrequency ablation or no treatment. Surg Oncol 21:e23–e30 CrossRef
20. Poon RT, Fan ST, Yu WC et al (2001) A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma. Arch Surg 136:693-99 CrossRef
21. Bruns H, Kratschmer K, Hinz U et al (2010) Quality of life after curative liver resection: a single center analysis. World J Gastroenterol 16:2388-395 CrossRef
22. Chen L, Liu Y, Li GG et al (2004) Quality of life in patients with liver cancer after operation: a 2-year follow-up study. Hepatobiliary Pancreat Dis Int 3:530-33
23. Dasgupta D, Smith AB, Hamilton-Burke W et al (2008) Quality of life after liver resection for hepatobiliary malignancies. Br J Surg 95:845-54 CrossRef
24. Eid S, Stromberg AJ, Ames S et al (2006) Assessment of symptom experience in patients undergoing hepatic resection or ablation. Cancer 107:2715-722 CrossRef
25. Langenhoff BS, Krabbe PF, Peerenboom L et al (2006) Quality of life after surgical treatment of colorectal liver metastases. Br J Surg 93:1007-014 CrossRef
26. Martin RC, Eid S, Scoggins CR et al (2007) Health-related quality of life: return to baseline after major and minor liver resection. Surgery 142:676-84 CrossRef
27. Makuuchi M, Kosuge T, Takayama T et al (1993) Surgery for small liver cancers. Semin Surg Oncol 9:298-04 CrossRef
28. Imamura H, Seyama Y, Kokudo N et al (2003) One thousand fifty-six hepatectomies without mortality in 8?years. Arch Surg 138:1198-206; discussion 1206 CrossRef
29. Hasegawa K, Kokudo N, Imamura H et al (2005) Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 242:252-59 CrossRef
30. Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187-96 CrossRef
31. Castaldo ET, Feurer ID, Russell RT et al (2009) Correlation of health-related quality of life after liver transplant with the model for end-stage liver disease score. Arch Surg 144:167-72 CrossRef
32. Fukuhara S, Bito S, Green J et al (1998) Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 51:1037-044 CrossRef
33. Fukuhara S, Ware JE Jr, Kosinski M et al (1998) Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J Clin Epidemiol 51:1045-053 CrossRef
34. Ware JE Jr (2000) SF-36 Health Survey update. Spine (Phila Pa 1976) 25:3130-139 CrossRef
35. Ware JE Jr, Gandek B (1998) Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 51:903-12 CrossRef
36. Pocard M, Sauvanet A, Regimbeau JM et al (2002) Limits and benefits of exclusive transthoracic hepatectomy approach for patients with hepatocellular carcinoma. Hepatogastroenterology 49:32-5
37. Shimada M, Matsumata T, Taketomi A et al (1995) A new approach for liver surgery: transdiaphragmatic hepatectomy for cirrhotic patients with hepatocellular carcinoma. Arch Surg 130:157-60 CrossRef
38. Yamazaki S, Takayama T, Moriguchi M et al (2012) Validation of biological and clinical outcome between with and without thoracotomy in liver resection: a matched cohort study. World J Surg 36:144-50. doi:10.1007/s00268-011-1320-3 CrossRef
39. Savage AP, Malt RA (1991) Elective and emergency hepatic resection: determinants of operative mortality and morbidity. Ann Surg 214:689-95 CrossRef
40. Stimpson RE, Pellegrini CA, Way LW (1987) Factors affecting the morbidity of elective liver resection. Am J Surg 153:189-96 CrossRef
41. Ahrendt SA, Schlossberg L, Bulkley GB (1999) Extended subcostal hinge incision for right hepatic lobectomy. Am Surg 65:774-76
42. Kise Y, Takayama T, Yamamoto J et al (1997) Comparison between thoracoabdominal and abdominal approaches in occurrence of pleural effusion after liver cancer surgery. Hepatogastroenterology 44:1397-400
43. Xia F, Poon RT, Fan ST et al (2003) Thoracoabdominal approach for right-sided hepatic resection for hepatocellular carcinoma. J Am Coll Surg 196:418-27 CrossRef
44. Huang ZY, Liang BY, Xiong M et al (2012) Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China. Ann Surg Oncol 19:2515-525 CrossRef
45. Itamoto T, Nakahara H, Amano H et al (2007) Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery 141:589-97 CrossRef
46. Kishi Y, Saiura A, Yamamoto J et al (2011) Repeat treatment for recurrent hepatocellular carcinoma: is it validated? Langenbecks Arch Surg 396:1093-100 CrossRef
47. Nakajima Y, Ko S, Kanamura T et al (2001) Repeat liver resection for hepatocellular carcinoma. J Am Coll Surg 192:339-44 CrossRef
48. Poon RT, Fan ST, Lo CM et al (1999) Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 229:216-22 CrossRef
49. Minagawa M, Makuuchi M, Takayama et al (2003) Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 238:703-10 CrossRef
50. Arrington-Sanders R, Yi MS, Tsevat J et al (2006) Gender differences in health-related quality of life of adolescents with cystic fibrosis. Health Qual Life Outcomes 4:5 CrossRef
51. Duenas M, Ramirez C, Arana R et al (2011) Gender differences and determinants of health related quality of life in coronary patients: a follow-up study. BMC Cardiovasc Disord 11:24 CrossRef
52. Katsura H, Yamada K, Wakabayashi R et al (2007) Gender-associated differences in dyspnoea and health-related quality of life in patients with chronic obstructive pulmonary disease. Respirology 12:427-32 CrossRef
53. Morishita S, Kaida K, Yamauchi S et al (2012) Gender differences in health-related quality of life, physical function and psychological status among patients in the early phase following allogeneic haematopoietic stem cell transplantation. Psychooncology 22:1159-166 CrossRef
54. Mrus JM, Williams PL, Tsevat J et al (2005) Gender differences in health-related quality of life in patients with HIV/AIDS. Qual Life Res 14:479-91 CrossRef
55. Westbrook JI, Talley NJ, Westbrook MT (2002) Gender differences in the symptoms and physical and mental well-being of dyspeptics: a population based study. Qual Life Res 11:283-91 CrossRef - 作者单位：Yoshihiro Mise (1)
Shouichi Satou (1)
Takeaki Ishizawa (1)
Junichi Kaneko (1)
Taku Aoki (1)
Kiyoshi Hasegawa (1)
Yasuhiko Sugawara (1)
Masatoshi Makuuchi (2)
Norihiro Kokudo (1)
1. Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
2. Department of Hepato-Biliary-Pancreatic Surgery, Japanese Red Cross Medical Center, Tokyo, Japan - ISSN：1432-2323
文摘
Background Liver resection is the mainstay of curative treatment for localized hepatocellular carcinoma (HCC). However, the impact of surgery for HCC on quality of life (QOL) has not been well assessed. Methods Health-related QOL was assessed using the Short Form-36 questionnaire in 108 patients who underwent a liver resection for HCC between January 2004 and January 2008. The QOL assessment was scheduled before and every 3?months after the operation. Patients were divided into two groups based on patient-, tumor-, and surgery-related variables. The physical component summary (PCS) and mental component summary (MCS) were compared between the two groups. Results Altogether, 69 patients (64?%) completed the consecutive QOL assessments until 6?months after surgery. At 3?months, the PCS scores were significantly lower for women and for patients who had undergone thoracotomy than among men (p?=?0.010) and patients who had not undergone thoracotomy (p?=?0.048), respectively. No significant differences in any of the PCS scores were observed at 6?months. No significant differences in the MCS scores were observed between the groups throughout the investigation, and improvement relative to the preoperative status was observed at 6?months. Conclusions Physical impairments in the QOL after surgery had returned to the baseline at 6?months, and the postoperative mental QOL improved relative to the preoperative state. The surgical candidates were expected to have a satisfactory QOL regardless of the preoperative status and surgical outcomes. A thoracoabdominal approach had a transient negative impact on the physical health status.